arrow
A

Anthony K.C. Chan

mcmaster university
H指数:72
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of anticoagulation for pediatric cerebral sinovenous thrombosis: systematic review and meta-analysis

抗凝治疗对儿童脑静脉窦血栓形成疗效和安全性的系统评价与Meta分析

2026-08-010
PRE
Concizumab in patients with hemophilia A or B without inhibitors: 56-week cutoff results of the phase 3 explorer8 study

利扎珠单抗在无抑制剂的A型或B型血友病患者中的疗效:第3期explorer8研究56周截断结果

2026-06-260
OA
ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism

ASH ISTH 2026年关于静脉血栓栓塞症高风险儿科患者抗凝预防的指南

2026-04-080
OAAI
Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysis

儿童静脉血栓栓塞症溶栓治疗的有效性与安全性:一项系统评价和Meta分析

2025-06-270
OAAI
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial
2024-12-011
PRE
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A
2024-07-185
PRE
Canadian clinical experience on switching from standard half-life recombinant factor VIII (rFVIII), octocog alfa, to extended half-life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada

加拿大在血友病A ≥ 12年的人群中从标准半衰期重组因子VIII (rFVIII),octocog alfa转换为延长半衰期rFVIII,damocog alfa pegol的临床经验,随后在加拿大进行了全面的血友病护理计划

2024-02-204
OA